Hildesheim, Franziska E.
Benedict, Ralph H. B.
Zivadinov, Robert
Dwyer, Michael G.
Fuchs, Tom
Jakimovski, Dejan
Weinstock-Guttman, Bianca
Bergsland, Niels https://orcid.org/0000-0002-7792-0433
Funding for this research was provided by:
National Center for Advancing Translational Sciences of the National Institutes of Health (UL1TR001412)
Article History
Received: 4 January 2021
Revised: 23 April 2021
Accepted: 4 May 2021
First Online: 16 May 2021
Declarations
:
: Franziska Hildesheim, Tom Fuchs, Dejan Jakimovski, and Niels Bergsland have nothing to disclose. Ralph H. B. Benedict has received research support from Accorda, Novartis, Genzyme, Biogen Idec, and Mallinkrodt, and is on the speakers’ bureau for EMD Serono, and consults for Biogen Idec, Genentech, Roche, Sanofi/Genzyme, Takeda, NeuroCog Trials, and Novartis. Dr. Benedict also receives royalties for Psychological Assessment Resources. Robert Zivadinov received personal compensation from EMD Serono, Sanofi, Bristol Myers Squibb, Keystone Heart and Novartis for speaking and consultant fees. He received financial support for research activities from Novartis, Protembis, Bristol Myers Squibb, Keystone Heart, Mapi Pharma, V-WAVE Medical and Boston Scientific. Michael G. Dwyer has received consultant fees from Claret Medical and EMD Serono and research grant support from Novartis. Bianca Weinstock-Guttman received honoraria as a speaker and/or as a consultant for Biogen Idec, EMD Serono, Genentech, Novartis, Mallinckrodt, Celgene, Abbvie. Dr Weinstock-Guttman received research funds from Biogen Idec, EMD Serono, Genentech, and Novartis.